Your browser doesn't support javascript.
loading
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer.
Forde, Patrick M; Spicer, Jonathan; Lu, Shun; Provencio, Mariano; Mitsudomi, Tetsuya; Awad, Mark M; Felip, Enriqueta; Broderick, Stephen R; Brahmer, Julie R; Swanson, Scott J; Kerr, Keith; Wang, Changli; Ciuleanu, Tudor-Eliade; Saylors, Gene B; Tanaka, Fumihiro; Ito, Hiroyuki; Chen, Ke Neng; Liberman, Moishe; Vokes, Everett E; Taube, Janis M; Dorange, Cecile; Cai, Junliang; Fiore, Joseph; Jarkowski, Anthony; Balli, David; Sausen, Mark; Pandya, Dimple; Calvet, Christophe Y; Girard, Nicolas.
Afiliación
  • Forde PM; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Kimmel Cancer Center, Baltimore, MD, USA.
  • Spicer J; McGill University Health Center, Montréal, Québec, Canada.
  • Lu S; Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Provencio M; Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Mitsudomi T; Kindai University Faculty of Medicine, Ohno-Higashi, Osaka-Sayama, Osaka, Japan.
  • Awad MM; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Felip E; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Broderick SR; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Kimmel Cancer Center, Baltimore, MD, USA.
  • Brahmer JR; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Kimmel Cancer Center, Baltimore, MD, USA.
  • Swanson SJ; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kerr K; Aberdeen Royal Infirmary, Aberdeen, United Kingdom.
  • Wang C; Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
  • Ciuleanu TE; Institutul Oncologic Prof. Dr. Ion Chiricuta & Universitatea de Medicina si Farmacie Iuliu Hatieganu, Cluj-Napoca, Romania.
  • Saylors GB; Charleston Oncology, Charleston, SC, USA.
  • Tanaka F; University of Occupational & Environmental Health, Kitakyushu, Japan.
  • Ito H; Kanagawa Cancer Center, Yokohama, Japan.
  • Chen KN; Peking University School of Oncology, Beijing Cancer Hospital, Beijing, China.
  • Liberman M; Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
  • Vokes EE; University of Chicago Medicine, Chicago, IL, USA.
  • Taube JM; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Kimmel Cancer Center, Baltimore, MD, USA.
  • Dorange C; Bristol Myers Squibb, Braine-L'Alleud, Belgium.
  • Cai J; Bristol Myers Squibb, Princeton, NJ, USA.
  • Fiore J; Bristol Myers Squibb, Princeton, NJ, USA.
  • Jarkowski A; Bristol Myers Squibb, Princeton, NJ, USA.
  • Balli D; Bristol Myers Squibb, Princeton, NJ, USA.
  • Sausen M; Bristol Myers Squibb, Princeton, NJ, USA.
  • Pandya D; Bristol Myers Squibb, Princeton, NJ, USA.
  • Calvet CY; Bristol Myers Squibb, Princeton, NJ, USA.
  • Girard N; Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France.
Future Oncol ; 19(8): 549-557, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36815433
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Humans Idioma: En Revista: Future Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Humans Idioma: En Revista: Future Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos